400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Immunology/Inflammation / FLAP / Fiboflapon
CAS No.: 936350-00-4
Synonyms: GSK2190915;AM-803
GSK2190915 is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00812929 | Asthma | Phase 2 | Completed | - | United States, Colorado ... more >> GSK Investigational Site Denver, Colorado, United States, 80230 United States, Massachusetts GSK Investigational Site North Dartmouth, Massachusetts, United States, 02747 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73120 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina GSK Investigational Site Orangeburg, South Carolina, United States, 29118 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79925 Collapse << |
NCT00812929 | - | - | Completed | - | - |
NCT01286844 | Asthma | Phase 2 | Withdrawn | May 2011 | - |
实验方案
技术信息
CAS号 | 936350-00-4 | 储存条件 |
|
|
分子式 | C38H43N3O4S | 运输 | 蓝冰 | |
分子量 | 637.83 | 别名 | GSK2190915;AM-803 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00812929 | Asthma | Phase 2 | Completed | - | United States, Colorado ... more >> GSK Investigational Site Denver, Colorado, United States, 80230 United States, Massachusetts GSK Investigational Site North Dartmouth, Massachusetts, United States, 02747 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73120 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina GSK Investigational Site Orangeburg, South Carolina, United States, 29118 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79925 Collapse << |
NCT00812929 | - | - | Completed | - | - |
NCT01286844 | Asthma | Phase 2 | Withdrawn | May 2011 | - |
NCT01147744 | Asthma | Phase 2 | Completed | - | - |
NCT00812773 | Asthma | Phase 2 | Completed | - | United Kingdom ... more >> GSK Investigational Site London, United Kingdom, NW10 7EW GSK Investigational Site London, United Kingdom, W1G 8HU GSK Investigational Site Manchester, United Kingdom, M23 9QZ Collapse << |
NCT01156792 | Asthma | Phase 2 | Completed | - | - |
NCT00748306 | Asthma | Phase 2 | Completed | - | Netherlands ... more >> GSK Investigational Site Leiden, Netherlands, 2333 CL United Kingdom GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site London, United Kingdom, NW10 7EW GSK Investigational Site London, United Kingdom, W1G 8HU Collapse << |
NCT01248975 | Asthma | Phase 2 | Completed | - | Bulgaria ... more >> GSK Investigational Site Pleven, Bulgaria, 5800 GSK Investigational Site Ruse, Bulgaria, 7000 GSK Investigational Site Varna, Bulgaria, 9010 Poland GSK Investigational Site Bialystok, Poland, 15-084 GSK Investigational Site Lodz, Poland, 93-329 GSK Investigational Site Tarnow, Poland, 33-100 Ukraine GSK Investigational Site Dnipropetrovsk, Ukraine, 49027 GSK Investigational Site Dnipropetrovsk, Ukraine, 49051 GSK Investigational Site Donetsk, Ukraine, 83099 GSK Investigational Site Ivano-Frankivsk, Ukraine, 76018 GSK Investigational Site Kharkiv, Ukraine, 61035 GSK Investigational Site Kharkiv, Ukraine, 61037 GSK Investigational Site Kiev, Ukraine, 03680 GSK Investigational Site Kiev, Ukraine, 3680 GSK Investigational Site Kyiv, Ukraine, 02091 GSK Investigational Site Kyiv, Ukraine, 02232 GSK Investigational Site Kyiv, Ukraine, 03115 GSK Investigational Site Kyiv, Ukraine, 04107 GSK Investigational Site Zaporizhia, Ukraine, 69035 Collapse << |
NCT00850642 | Asthma | Phase 2 | Terminated | - | Canada, Ontario ... more >> GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 United Kingdom GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN GSK Investigational Site Leicester, Leicestershire, United Kingdom, LE3 9QP GSK Investigational Site London, United Kingdom, NW10 7EW GSK Investigational Site Manchester, United Kingdom, M23 9QZ Collapse << |
NCT02224521 | Asthma | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site London, United Kingdom, NW10 7EW Collapse << |
NCT01147744 | - | - | Completed | - | - |
NCT01318980 | Asthma | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Nottingham, United Kingdom, NG11 6JS Collapse << |
NCT01156792 | - | - | Completed | - | - |
NCT01721135 | Asthma | Phase 1 | Withdrawn(Study was terminated... more >> due to toxicology findings after screening started but before first subject first dose.) Collapse << | December 2014 | United Kingdom ... more >> GSK Investigational Site London, United Kingdom, NW10 7EW Collapse << |
NCT01411111 | Asthma | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site London, United Kingdom, NW10 7EW Collapse << |
NCT00850642 | - | - | Terminated | - | - |
NCT01471665 | Asthma | Phase 2 | Completed | - | United Kingdom ... more >> GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN Collapse << |
NCT00955383 | Asthma | Phase 1 | Completed | - | Germany ... more >> GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网